Lv5
844 积分 2022-11-01 加入
[Advances in targeted and immune therapies for hepatocellular carcinoma]
3天前
已完结
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
4天前
已完结
Bone marrow-based highly sensitive proteomics profiling reveals valuable biomarkers for pediatric B-cell acute lymphoblastic leukemia
16天前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
16天前
已完结
SAICAR Drives T Regulatory Cell Differentiation and FOXP3 Maintenance to Promote Immunotherapy Resistance
18天前
已完结
Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion
20天前
已完结
Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7+CD8+ T-cell entry into HCC through high endothelial venules
21天前
已完结
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
23天前
已完结
Letter to the editor: the inflamed subclass predicts immunotherapy response – external validations
24天前
已完结
Migrasome-related ITGA5 for predicting prognosis, immune infiltration and drug sensitivity of hepatocellular carcinoma
24天前
已完结
皖公网安备34019202002308
